Below are the most recent publications written about "Vasodilator Agents" by people in Profiles.
-
Rocha DG, Holanda TM, Braz HLB, de Moraes JAS, Marinho AD, Maia PHF, de Moraes MEA, Fechine-Jamacaru FV, de Moraes Filho MO. Vasorelaxant effect of Alpinia zerumbet's essential oil on rat resistance artery involves blocking of calcium mobilization. Fitoterapia. 2023 Sep; 169:105623.
-
Chang C, White C, Katz A, Hanna MK. Management of ischemic tissues and skin flaps in Re-Operative and complex hypospadias repair using vasodilators and hyperbaric oxygen. J Pediatr Urol. 2020 Oct; 16(5):672.e1-672.e8.
-
Rom?n M, Ram?rez JM, Morales M, Crespo MJ. Significant reduction of vascular reactivity with dantrolene and nimodipine in diabetic rats: a potential approach to cerebral vasospasm management in diabetes. Pharmacol Rep. 2020 Feb; 72(1):126-134.
-
Yang HJ, Dey D, Sykes J, Klein M, Butler J, Kovacs MS, Sobczyk O, Sharif B, Bi X, Kali A, Cokic I, Tang R, Yumul R, Conte AH, Tsaftaris SA, Tighiouart M, Li D, Slomka PJ, Berman DS, Prato FS, Fisher JA, Dharmakumar R. Arterial CO2 as a Potent Coronary Vasodilator: A Preclinical PET/MR Validation Study with Implications for Cardiac Stress Testing. J Nucl Med. 2017 06; 58(6):953-960.
-
Pietras DA, Lopez FR, Per?z R, L?pez-Candales A, Elwing J. Worsening gradient of aortic stenosis with treatment of pulmonary arterial hypertension in scleroderma. Bol Asoc Med P R. 2015 Jan-Mar; 107(1):41-4.
-
Modolo R, de Faria AP, Paganelli MO, Sabbatini AR, Barbaro NR, Nascimento BB, Ramos CD, Fontana V, Calhoun DA, Moreno H. Predictors of silent myocardial ischemia in resistant hypertensive patients. Am J Hypertens. 2015 Feb; 28(2):200-7.
-
Yang HJ, Yumul R, Tang R, Cokic I, Klein M, Kali A, Sobczyk O, Sharif B, Tang J, Bi X, Tsaftaris SA, Li D, Conte AH, Fisher JA, Dharmakumar R. Assessment of myocardial reactivity to controlled hypercapnia with free-breathing T2-prepared cardiac blood oxygen level-dependent MR imaging. Radiology. 2014 Aug; 272(2):397-406.
-
Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, D?vila-Rom?n VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18; 310(23):2533-43.
-
Huang H, Wang H, Figueiredo-Pereira ME. Regulating the ubiquitin/proteasome pathway via cAMP-signaling: neuroprotective potential. Cell Biochem Biophys. 2013 Sep; 67(1):55-66.
-
Pacurari M, Xing D, Hilgers RH, Guo YY, Yang Z, Hage FG. Endothelial cell transfusion ameliorates endothelial dysfunction in 5/6 nephrectomized rats. Am J Physiol Heart Circ Physiol. 2013 Oct 15; 305(8):H1256-64.